Work

Preclinical Evaluation of AT219, a Small Molecule Inhibitor of MDM2 As an Anti-Myeloma Agent.

Year: 2012

Type: article

Source: Blood

DOI: 10.1182/blood.v120.21.2948.2948

Authors: Vijay G. Ramakrishnan, Teresa K. Kimlinger, Timothy Halling, Jessica Haug, Utkarsh Painuly, S. Vincent Rajkumar, Shaji K. Kumar

Institution: Mayo Clinic

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2555646772

FWCI:

Cites:

Cited by:

Related to: 10